People: Kalvista Pharmaceuticals Inc (KALV.OQ)
12 Aug 2020
Mr. Benjamin (Ben) L. Palleiko serves as Chief Financial Officer, Chief Business Officer of the Company. Mr. Palleiko was appointed as our Chief Business Officer in addition to his role as Chief Financial Officer in March 2019. Prior to joining us, Mr. Palleiko was a Managing Director of H.C. Wainwright & Co. LLC since January 2015. He previously was Senior Vice President and Chief Financial Officer of Ore Pharmaceutical Holdings Inc. and Penwest Pharmaceuticals Co., and Chief Financial Officer of Nostrum Pharmaceuticals LLC. Earlier in his career Mr. Palleiko was an investment banker with the firms Robertson Stephens and SunTrust Bank. Mr. Palleiko holds a B.A. in Quantitative Economics from Tufts University and an M.B.A. in Finance and M.A. in International Relations from the University of Chicago. He served as a Naval Aviator in the U.S. Navy.
|Total Annual Compensation, USD||558,150|
|Restricted Stock Award, USD||527,794|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,005,560|
|Fiscal Year Total, USD||2,091,500|